The ATC (Anatomical Therapeutic Chemical classification system) main group that generated the highest sales value of prescription pharmaceuticals in Norway in 2021 was the group of antineoplastic and immunomodulating agents. The sales value for this ATC main group was around 10.8 billion Norwegian kroner.
Sales of pharmaceuticals in Norway in 2021, by ATC main group
(in million NOK)
Characteristic
Sales in million NOK
Antineoplastic and immunomodulating agents
10,835.9
Central nervous system
3,765.7
Alimentary tract and metabolism
3,126.9
Antiinfectives for systematic use
2,746.5
Blood and blood forming organs
2,657.3
Respiratory system
1,887.1
Cardiovascular system
1,382.7
Genito-urinary system and sex hormones
1,267.6
Musculo-skeletal system
990.3
Sensory organs
692.1
Systematic hormonal preparations*
635
Dermatologicals
619.7
Antiparasitic products, insecticides and repellents
Sales of medicines in 2021 divided into therapeutic groups, according to the ATC system. The table is based on the first level of the ATC system; anatomical main group. The amounts are stated in AIP (pharmacies' purchase price).
From January 2017, the values ​​for medicines included in the hospital offers, as well as H prescriptions, are calculated without discounts. The values ​​in the calculation basis are converted to the maximum AIP (pharmacies' purchase price).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Legemiddelindustrien. (March 14, 2022). Sales of pharmaceuticals in Norway in 2021, by ATC main group (in million NOK) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/945238/sales-of-reimbursed-drugs-in-norway-by-atc-main-groups/
Legemiddelindustrien. "Sales of pharmaceuticals in Norway in 2021, by ATC main group (in million NOK) ." Chart. March 14, 2022. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/945238/sales-of-reimbursed-drugs-in-norway-by-atc-main-groups/
Legemiddelindustrien. (2022). Sales of pharmaceuticals in Norway in 2021, by ATC main group (in million NOK) . Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/945238/sales-of-reimbursed-drugs-in-norway-by-atc-main-groups/
Legemiddelindustrien. "Sales of Pharmaceuticals in Norway in 2021, by Atc Main Group (in Million Nok) ." Statista, Statista Inc., 14 Mar 2022, https://www-statista-com.ezproxy.canberra.edu.au/statistics/945238/sales-of-reimbursed-drugs-in-norway-by-atc-main-groups/
Legemiddelindustrien, Sales of pharmaceuticals in Norway in 2021, by ATC main group (in million NOK) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/945238/sales-of-reimbursed-drugs-in-norway-by-atc-main-groups/ (last visited November 10, 2024)
Sales of pharmaceuticals in Norway in 2021, by ATC main group (in million NOK) [Graph], Legemiddelindustrien, March 14, 2022. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/945238/sales-of-reimbursed-drugs-in-norway-by-atc-main-groups/
